Defining patient‐centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Zeyu Zhu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Alzheimer Disease, Tauopathies, Amyloid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association, Gerhard and Ilse Schick Foundation, ERAPerMed.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Amyloid‐induced tauopathy drives clinical decline in Alzheimer's disease (AD). Because age and sex shape tau trajectories, defining patient‐centered amyloid thresholds for tauopathy onset could facilitate pre‐tauopathy AD identification and aid treatment decisions and prognosis. METHODS By including two samples (Alzheimer's Disease Neuroimaging Initiative [ADNI, n = 301]; and 18F‐AV‐1451‐A05 [A05, n = 143]), we explored whether age and sex affect tauopathy transition and determined patient‐centered amyloid positron emission tomography (PET) thresholds that mark tauopathy onset. RESULTS We found a consistent amyloid PET × age interaction on global tau PET increase in men (ADNI/A05: p = 0.0078/0.018), with younger men showing faster amyloid‐associated tau accumulation. We then established patient‐centered, amyloid PET–inferred tauopathy transition cut‐offs. Women reached this transition at lower amyloid PET levels, and these cutoffs predicted both earlier onset and accelerated cognitive decline ( p < 0.001). DISCUSSION This study highlights the effect of age and sex on the amyloid‐to‐tauopathy transition, establishes patient‐centered amyloid PET thresholds for tauopathy onset, and links these thresholds to accelerated cognitive decline. Highlights Younger age is related to faster amyloid‐related tau accumulation in men. We defined a series of amyloid positron emission tomography (PET) thresholds to enable patient‐centered inference of amyloid‐related tauopathy. Crossing the amyloid PET–defined tauopathy phase is associated with more progressive tau deposition and cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
- Department of Neurology, University Hospital, LMU Munich, Munich, Germany.
- Max Planck School of Cognition, Leipzig, Germany.
- Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
- Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Nicolai Franzmeier
Förderung
- Alzheimer's Association
- Gerhard and Ilse Schick Foundation
- ERAPerMed
Zitieren
APA
Zhu, Z., Steward, A., Dehsarvi, A., Roemer-Cassiano, S. N., Dewenter, A., Biel, D., Hirsch, F., Frontzkowski, L., Pescoller, J., Klonowski, M., Gnörich, J., Pontecorvo, M. J., Shcherbinin, S., Schöll, M., Buckley, R., Ossenkoppele, R., Xie, F., Guo, T., Alzheimer's Disease Neuroimaging Initiative, …, & Franzmeier, N. (2026). Defining patient‐centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71064
Vancouver
Zhu Z, Steward A, Dehsarvi A, Roemer-Cassiano SN, Dewenter A, Biel D, et al. Defining patient‐centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71064
BibTeX
@article{Zhu2026,
author = {Zhu, Zeyu and Steward, Anna and Dehsarvi, Amir and Roemer-Cassiano, Sebastian N and Dewenter, Anna and Biel, Davina and Hirsch, Fabian and Frontzkowski, Lukas and Pescoller, Julia and Klonowski, Madleen and Gnörich, Johannes and Pontecorvo, Michael J and Shcherbinin, Sergey and Schöll, Michael and Buckley, Rachel and Ossenkoppele, Rik and Xie, Fang and Guo, Tengfei and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Höglinger, Günter and Brendel, Matthias and Franzmeier, Nicolai},
title = {Defining patient‐centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71064}
}
EUVIMED